NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $100,796,323 | +56.4% | 2,277,883 | +72.0% | 0.50% | +50.7% |
Q2 2023 | $64,434,745 | +75.4% | 1,324,183 | +100.1% | 0.34% | +65.0% |
Q1 2023 | $36,742,192 | +538.7% | 661,783 | +362.1% | 0.20% | +497.1% |
Q4 2022 | $5,752,344 | -42.4% | 143,200 | -37.2% | 0.03% | -38.2% |
Q3 2022 | $9,989,000 | +22.2% | 227,953 | -1.1% | 0.06% | +22.2% |
Q2 2022 | $8,171,000 | -81.8% | 230,552 | -79.1% | 0.04% | -79.2% |
Q1 2022 | $44,799,000 | -67.4% | 1,101,252 | -25.2% | 0.22% | -68.6% |
Q4 2021 | $137,537,000 | -5.1% | 1,472,715 | +13.3% | 0.69% | +1.6% |
Q3 2021 | $144,887,000 | +155.2% | 1,300,134 | +160.0% | 0.68% | +191.4% |
Q2 2021 | $56,765,000 | – | 500,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |